Immunogenicity and Safety Study of GSK Biologicals' Candidate Malaria Vaccine Given at 6, 7.5 and 9 Months of Age in Co-administration With Measles, Rubella and Yellow Fever (YF) Vaccines Followed by a Booster of the Malaria Vaccine.

NCT02699099 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

699

Enrollment

INDUSTRY

Sponsor class

Conditions

Malaria
Malaria Vaccines

Interventions

DIETARY_SUPPLEMENT: Vitamin A
BIOLOGICAL: Candidate Plasmodium falciparum malaria vaccine
BIOLOGICAL: MR-Vac
BIOLOGICAL: Stamaril

Sponsor

GlaxoSmithKline